Telephone Nurse Counseling for Medication Adherence in Ulcerative Colitis: a Preliminary Study
Overview
Nursing
Affiliations
Objective: Adherence is challenging in episodic chronic conditions that require medication during both symptomatic and quiescent periods, such as ulcerative colitis (UC). Adherence for these conditions is under-studied. This study was a preliminary test of telephone nurse counseling to address cognitive and emotional barriers to adherence in UC.
Methods: 524 people taking mesalamine for UC were referred by their health care providers, and 278 (53%) enrolled. There were no demographic differences between program participants and nonparticipants. Participants reported multiple comorbidities and concomitant medications. All participants received telephone follow-up (M = 2.1 calls) from a registered nurse who used cognitive-behavioral and motivational interviewing counseling techniques. Adherence measured by structured interview was compared to a population baseline using a binomial test.
Results: Attrition was 51% over 6 months but was unrelated to adherence. Participants had better adherence than the expected population rate, with a significant dose-response effect. Reasons for nonadherence were primarily psychological or efficacy-related.
Conclusion: Adherence following intervention was better than typical mesalamine adherence. Self-efficacy predicted adherence, but demographic and clinical variables did not. Adherent participants reported more adverse events.
Practice Implications: Attention to patients' cognitive and emotional reactions may help to improve adherence in episodic chronic diseases such as UC.
Shahkaram H, Sadeghi A, Masjedi Arani A, Bakhtiari M, Kianimoghadam A Gastroenterol Hepatol Bed Bench. 2024; 17(3):288-296.
PMID: 39308538 PMC: 11413384. DOI: 10.22037/ghfbb.v17i3.2920.
Dhunnoo P, Kemp B, McGuigan K, Mesko B, ORourke V, McCann M J Med Internet Res. 2024; 26:e53266.
PMID: 38980704 PMC: 11267102. DOI: 10.2196/53266.
Mercuri C, Catone M, Bosco V, Guillari A, Rea T, Doldo P Healthcare (Basel). 2024; 12(12).
PMID: 38921325 PMC: 11204356. DOI: 10.3390/healthcare12121210.
Ren C, Zhou Y, Cai Q, Zhou M Digit Health. 2024; 10:20552076241261906.
PMID: 38868366 PMC: 11168054. DOI: 10.1177/20552076241261906.
Telemedicine in inflammatory bowel diseases: A new brick in the medicine of the future?.
Gravina A, Pellegrino R, Durante T, Palladino G, DOnofrio R, Mammone S World J Methodol. 2023; 13(4):194-209.
PMID: 37771865 PMC: 10523254. DOI: 10.5662/wjm.v13.i4.194.